Vertex Pharmaceuticals

Vertex Pharmaceuticals

Organization

Heard in 22 episodes across 14 shows since Dec 2025

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotechnology firms to utilize an explicit strategy of rational drug design rather than combinatorial chemistry. The company focuses on developing and commercializing therapies for treating serious diseases, notably cystic fibrosis.

Discussed inMarkets91%AI & Tech9%

Episodes

22
across 14 shows

This week

0
episodes on 0 shows

Expert statements

7
4 positive

Share of the conversation

Mentions of Vertex Pharmaceuticals per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Sep 20.01‰1
Sep 130.01‰1
Oct 160.01‰1
Oct 230.01‰1
Oct 280.02‰1
Oct 300.03‰2
Nov 20.03‰1
Nov 30.04‰1
Nov 60.03‰2
Nov 120.02‰1
Nov 130.02‰1
Nov 150.02‰1
Nov 200.02‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Vertex Pharmaceuticals comes up on a podcast

One email a week at most, with the new episodes that mention Vertex Pharmaceuticals. Free, no account needed, unsubscribe in one click.

What experts have said about Vertex Pharmaceuticals

7 statements · 4 positive · 3 neutral

  1. Dan CurtisNeutralJul 7, 2026· Stock Movers

    Vertex agreed to acquire Crinetics for $10 billion in cash.

    “Vertex has agreed to buy Crenex for $10 billion in cash.”

    Listen at 3:54

    Open the episode · Micron and Sandisk Drop; SpaceX Rating; Crinetics Soars
  2. Dan CurtisPositiveJul 7, 2026· Stock Movers

    The Crinetics acquisition will give Vertex entry into endocrinology.

    “This will give Vertex an entry into the endocrinology market.”

    Listen at 4:09

    Open the episode · Micron and Sandisk Drop; SpaceX Rating; Crinetics Soars
  3. Emily GraffeoPositiveJul 6, 2026· Stock Movers

    Vertex Pharmaceuticals agreed to acquire Kinetics Pharma for $85 per share.

    “Vertex Pharmaceuticals agreeing to acquire kinetics Pharma for 85 bucks a share.”

    Listen at 1:07

    Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf Jumps

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

22 episodes featuring Vertex Pharmaceuticals, newest first